Dapayan-M Tablet ER
Marketer
Nirosha Lifesciences
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapayan-M Tablet ER
Diabetic patients with type 2 mellitus may find relief with the extended-release Dapayan-M Tablet, a dual-medication formulation. This medication effectively manages elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular health. Dapayan-M Tablet ER is administered with meals, consistently at the same time daily to improve adherence. Dosage is determined individually by your physician and should never be altered without their consent; abrupt cessation can lead to dangerously high blood sugar, potentially causing kidney failure or vision loss. This medication forms part of a comprehensive treatment strategy incorporating a doctor-recommended diet, regular physical activity, and weight management. Common side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration may occur; increased fluid intake is advised. Genital fungal infections are a possibility; diligent hygiene practices can help reduce this risk. Prior to commencing treatment, disclose any pre-existing kidney or liver disease, urinary tract infections, diuretic use, or pregnancy/breastfeeding status to your doctor. Limit alcohol consumption to minimize potential side effects. Regular blood glucose monitoring is essential while using this medication.
Primary Ingredients of Dapayan-M Tablet ER
No information provided. A rewritten text cannot be produced.
Uses of Dapayan-M Tablet ER
Managing type 2 diabetes
Major Benefits of Dapayan-M Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dapayan-M Extended Release tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer this medication with a meal.
Common Side effects of Dapayan-M Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapayan-M Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapayan-M Extended Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Dapayan-M Tablet ER works:
Dapagliflozin and Metformin, combined as Dapayan-M Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose output, slows intestinal glucose uptake, and improves insulin responsiveness. This dual-action approach leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Dapayan-M Extended Release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dapayan-M Tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapayan-M tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when prescribing Dapayan-M Extended-Release tablets to individuals with impaired renal function. Dosage modification of Dapayan-M Extended-Release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Dapayan-M Extended-Release tablets judiciously. Dosage modification of Dapayan-M Extended-Release tablets may be necessary; physician consultation is advised.
What if you forget to take Dapayan-M Tablet ER :
Should you forget a Dapayan-M Tablet ER dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapayan-M Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |



